Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.36 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.36 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.35 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.35 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.35 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.35 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.35 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3165316 | 0.98 | NPC1 (0.37) | NPC1RAB9ASIGMAR1P2RX7GRIN2D | |
| SCHEMBL3185842 | 0.98 | TSHR (0.36) | NPC1RAB9ASIGMAR1P2RX7GRIN2D | |
| SCHEMBL3170606 | 0.96 | TSHR (0.35) | NPC1RAB9ASIGMAR1P2RX7GRIN2D | |
| SCHEMBL15659453 | 0.90 | ACHE (0.39) | NPC1RAB9ATSHRACHELMNA | |
| SCHEMBL29391022 | 0.85 | S1PR1 (0.36) | NPC1RAB9ASIGMAR1P2RX7GRIN2D | |
| SCHEMBL197441 | 0.85 | S1PR1 (0.36) | NPC1RAB9ASIGMAR1P2RX7GRIN2D | |
| SCHEMBL29350531 | 0.85 | S1PR1 (0.36) | NPC1RAB9ASIGMAR1P2RX7GRIN2D | |
| SCHEMBL1315359 | 0.85 | ROCK2 (0.35) | TSHRACHELMNAROCK2ALOX12 | |
| SCHEMBL15660440 | 0.85 | GAA (0.40) | NPC1RAB9ASIGMAR1P2RX7TSHR | |
| SCHEMBL205843 | 0.85 | ROCK2 (0.38) | NPC1RAB9ASIGMAR1P2RX7GRIN2D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118388585-A | Preparation method of amide and ester compounds based on visible light catalysis | 泰山学院 | 2024-07-26 | — | — | CN | claimed |
| WO-2019016115-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED ARYL KETONES | BASF Agro B.V. (NL) | 2019-01-24 | — | — | WO | claimed |
| US-6686495-B2 | IN PRESENCE OF PALLADIUM CATALYST; USEFUL IN PRODUCING CHEMICAL INTERMEDIATES FOR PHARMACEUTICALS, OPTICAL BRIGHTENING AGENTS AND AGROCHEMICALS | OMG AG & CO KG (DE) | 2004-02-03 | — | — | US | claimed |
| US-20020107426-A1 | Process for the preparation of mono-, bi- or poly- functional biaryls | UMICORE AG & CO. KG (DE) | 2002-08-08 | — | — | US | claimed |
| EP-1199292-A1 | Process for the production of mono-, bi- or polyfunctional biaryls | OMG AG & Co. KG (DE) | 2002-04-24 | — | — | EP | claimed |
| EP-3892611-B1 | METHOD FOR PRODUCING FLUOROVINYL AMIDE COMPOUND | DAIKIN IND LTD (JP) | 2026-01-28 | — | — | EP | disclosed |
| US-20250214936-A1 | METHOD FOR PRODUCING FLUOROVINYL AMIDE COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2025-07-03 | — | — | US | disclosed |
| US-12281075-B2 | Method for producing fluorovinyl amide compound | DAIKIN INDUSTRIES, LTD. (JP) | 2025-04-22 | — | — | US | disclosed |
| WO-2025016436-A1 | PREPARATION METHOD FOR KRAS INHIBITOR, INTERMEDIATE THEREOF AND PREPARATION METHOD FOR INTERMEDIATE THEREOF | 上海济煜医药科技有限公司 | 2025-01-23 | — | — | WO | disclosed |
| CN-118388585-A | Preparation method of amide and ester compounds based on visible light catalysis | 泰山学院 | 2024-07-26 | — | — | CN | disclosed |
| US-11932596-B2 | Fluorovinyl ether compound | DAIKIN INDUSTRIES, LTD. (JP) | 2024-03-19 | — | — | US | disclosed |
| EP-3643694-B1 | METHOD FOR PRODUCING BUTADIENE COMPOUND | DAIKIN IND LTD (JP) | 2023-11-15 | — | — | EP | disclosed |
| US-20040082814-A1 | Process for producing retinol and intermediate compounds for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2004-04-29 | — | — | US | disclosed |
| US-6686495-B2 | IN PRESENCE OF PALLADIUM CATALYST; USEFUL IN PRODUCING CHEMICAL INTERMEDIATES FOR PHARMACEUTICALS, OPTICAL BRIGHTENING AGENTS AND AGROCHEMICALS | OMG AG & CO KG (DE) | 2004-02-03 | — | — | US | disclosed |
| US-6660888-B2 | A disulfone compound of given formula | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-12-09 | — | — | US | disclosed |
| US-20020107426-A1 | Process for the preparation of mono-, bi- or poly- functional biaryls | UMICORE AG & CO. KG (DE) | 2002-08-08 | — | — | US | disclosed |
| CN-1356317-A | Process for producing retinol and intermediate compound for producing retinol | SUMITOMO CHEMICAL CO (JP) | 2002-07-03 | — | — | CN | disclosed |
| US-20020058844-A1 | Process for producing retinol and intermediate compounds for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-05-16 | — | — | US | disclosed |
| EP-1199303-A1 | Process for producing retinol and intermediate compounds for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-04-24 | — | — | EP | disclosed |
| EP-1199292-A1 | Process for the production of mono-, bi- or polyfunctional biaryls | OMG AG & Co. KG (DE) | 2002-04-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11932596-B2 | Fluorovinyl ether compound | RB1, AFF1, AFF2 | NPC1 3797/4885RAB9A 649/4885SIGMAR1 4288/4885 |
| US-20040082814-A1 | Process for producing retinol and intermediate compounds for producing the same | ADH4, ADH1B, ADH7 | NPC1 2226/4885RAB9A 1374/4885SIGMAR1 1836/4885 |
| US-12281075-B2 | Method for producing fluorovinyl amide compound | RB1, KRAS, NRAS | NPC1 3488/4885RAB9A 318/4885SIGMAR1 4094/4885 |
| US-20250214936-A1 | METHOD FOR PRODUCING FLUOROVINYL AMIDE COMPOUND | RB1, KRAS, NRAS | NPC1 3488/4885RAB9A 318/4885SIGMAR1 4094/4885 |
| US-20020058844-A1 | Process for producing retinol and intermediate compounds for producing the same | ADH4, ADH1B, ADH7 | NPC1 2226/4885RAB9A 1374/4885SIGMAR1 1836/4885 |
| US-20020107426-A1 | Process for the preparation of mono-, bi- or poly- functional biaryls | CYP4F3, CYP4F2, CYP2F1 | NPC1 2800/4885RAB9A 2663/4885SIGMAR1 1502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.